{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:47:06Z","timestamp":1774676826743,"version":"3.50.1"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-2017-08-ST2-012"],"award-info":[{"award-number":["RP-2017-08-ST2-012"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>It is essential that clinical trial participants are representative of the population under investigation. Using HIV-associated cryptococcal meningitis (CM) as a case study, we conducted a systematic review of clinical trials to determine how inclusive and representative they were both in terms of the affected population and the involvement of local investigators.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We searched Medline, EMBASE, Cochrane, Africa-Wide, CINAHL Plus, and Web of Science. Data were extracted for 5 domains: study location and design, screening, participants, researchers, and funders. Data were summarised and compared over 3 time periods: pre-antiretroviral therapy (ART) (pre-2000), early ART (2000 to 2009), and established ART (post-2010) using chi-squared and chi-squared for trend. Comparisons were made with global disease burden estimates and a composite reference derived from observational studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Thirty-nine trials published between 1990 and 2019 were included. Earlier studies were predominantly conducted in high-income countries (HICs) and recent studies in low- and middle-income countries (LMICs). Most recent studies occurred in high CM incidence countries, but some highly affected countries have not hosted trials. The sex and ART status of participants matched those of the general CM population. Patients with reduced consciousness and those suffering a CM relapse were underrepresented. Authorship had poor representation of women (29% of all authors), particularly as first and final authors. Compared to trials conducted in HICs, trials conducted in LMICs were more likely to include female authors (32% versus 20% <jats:italic>p<\/jats:italic> = 0.014) but less likely to have authors resident in (75% versus 100%, <jats:italic>p<\/jats:italic> &lt; 0.001) or nationals (61% versus 93%, <jats:italic>p<\/jats:italic> &lt; 0.001) of the trial location.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>There has been a marked shift in CM trials over the course of the HIV epidemic. Trials are primarily performed in locations and populations that reflect the burden of disease, but severe and relapse cases are underrepresented. Most CM trials now take place in LMICs, but the research is primarily funded and led by individuals and institutions from HICs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0009376","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T17:28:53Z","timestamp":1622136533000},"page":"e0009376","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchers"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-4039","authenticated-orcid":true,"given":"David S.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-4693","authenticated-orcid":true,"given":"Tshepo","family":"Leeme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-0999","authenticated-orcid":true,"given":"Mosepele","family":"Mosepele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-4348","authenticated-orcid":true,"given":"Thomas S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-5272","authenticated-orcid":true,"given":"Janet","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-5554","authenticated-orcid":true,"given":"Joseph N.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"issue":"5","key":"pntd.0009376.ref001","doi-asserted-by":"crossref","first-page":"e002068","DOI":"10.1136\/bmjgh-2019-002068","article-title":"The foreign gaze: authorship in academic global health","volume":"4","author":"S Abimbola","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pntd.0009376.ref002","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","article-title":"Enrolling pregnant women: issues in clinical research","volume":"23","author":"MC Blehar","year":"2013","journal-title":"Womens Health Issues"},{"issue":"5","key":"pntd.0009376.ref003","doi-asserted-by":"crossref","first-page":"e001855","DOI":"10.1136\/bmjgh-2019-001855","article-title":"Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980\u20132016","volume":"4","author":"R Mbaye","year":"2019","journal-title":"BMJ Glob Health"},{"key":"pntd.0009376.ref004","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1186\/1472-6939-5-5","article-title":"Under-representation of developing countries in the research literature: ethical issues arising from a survey of five leading medical journals","volume":"5","author":"A Sumathipala","year":"2004","journal-title":"BMC Med Ethics"},{"issue":"2","key":"pntd.0009376.ref005","doi-asserted-by":"crossref","first-page":"e16878","DOI":"10.1371\/journal.pone.0016878","article-title":"Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection","volume":"6","author":"N Ahmad","year":"2011","journal-title":"PLoS ONE"},{"issue":"7519","key":"pntd.0009376.ref006","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/bmj.331.7519.742","article-title":"Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution","volume":"331","author":"N Siegfried","year":"2005","journal-title":"BMJ (Clinical research ed)"},{"issue":"12","key":"pntd.0009376.ref007","doi-asserted-by":"crossref","first-page":"e28759","DOI":"10.1371\/journal.pone.0028759","article-title":"Randomized Controlled Trials of HIV\/AIDS Prevention and Treatment in Africa: Results from the Cochrane HIV\/AIDS Specialized Register","volume":"6","author":"B Zani","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"pntd.0009376.ref008","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S2214-109X(17)30497-7","article-title":"Authorship trends in The Lancet Global Health","volume":"6","author":"AR Iyer","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pntd.0009376.ref009","volume-title":"Financing the Response to HIV in Low- and Middle-Income Countries:","author":"UNAIDS","year":"2016"},{"key":"pntd.0009376.ref010","volume-title":"Scrambling for Africa: AIDS, expertise and the rise of American Global Health science","author":"J Crane","year":"2013"},{"issue":"1","key":"pntd.0009376.ref011","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1038\/s41598-017-04527-6","article-title":"Global Trends and Regional Variations in Studies of HIV\/AIDS","volume":"7","author":"A Baghaei Lakeh","year":"2017","journal-title":"Sci Rep"},{"key":"pntd.0009376.ref012","volume-title":"Seizing The Moment: Tackling entrenched inequalities to end epidemics","author":"UNAIDS","year":"2020"},{"issue":"1","key":"pntd.0009376.ref013","doi-asserted-by":"crossref","first-page":"e25218","DOI":"10.1002\/jia2.25218","article-title":"Research priorities to inform \u201cTreat All\u201d policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA)","volume":"22","author":"M Yotebieng","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"10144","key":"pntd.0009376.ref014","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","article-title":"Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society\u2014Lancet Commission","volume":"392","author":"L-G Bekker","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"pntd.0009376.ref015","doi-asserted-by":"crossref","first-page":"e001853","DOI":"10.1136\/bmjgh-2019-001853","article-title":"Stuck in the middle: a systematic review of authorship in collaborative health research in Africa, 2014\u20132016","volume":"4","author":"BL Hedt-Gauthier","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"5","key":"pntd.0009376.ref016","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/cid\/cix430","article-title":"Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis","volume":"65","author":"MW Tenforde","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"pntd.0009376.ref017","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/cid\/cix1140","article-title":"The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa","volume":"66","author":"M Osler","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pntd.0009376.ref018","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"R Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pntd.0009376.ref019","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa","volume":"378","author":"SF Molloy","year":"2018","journal-title":"N Engl J Med"},{"key":"pntd.0009376.ref020","article-title":"Short Course High-dose Liposomal Amphotericin B for HIV-associated Cryptococcal Meningitis: A phase-II Randomized Controlled Trial","author":"J Jarvis","year":"2018","journal-title":"CID"},{"issue":"6","key":"pntd.0009376.ref021","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis","volume":"374","author":"J Beardsley","year":"2016","journal-title":"N Engl J Med"},{"key":"pntd.0009376.ref022","volume-title":"Covidence systematic review software"},{"issue":"11","key":"pntd.0009376.ref023","article-title":"High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B\u2013Based Therapy Under Routine Care Conditions in Africa","volume":"5","author":"RKK Patel","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"pntd.0009376.ref024","doi-asserted-by":"crossref","first-page":"e0004865","DOI":"10.1371\/journal.pntd.0004865","article-title":"Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa","volume":"10","author":"S Meiring","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0009376.ref025","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.4102\/phcfm.v6i1.672","article-title":"Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical audit","volume":"6","author":"BO Adeyemi","year":"2014","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"4 Suppl 3","key":"pntd.0009376.ref026","doi-asserted-by":"crossref","first-page":"19623","DOI":"10.7448\/IAS.17.4.19623","article-title":"Profile and mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal, South Africa","volume":"17","author":"B Adeyemi","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"pntd.0009376.ref027","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"RA Larsen","year":"1990","journal-title":"Ann Intern Med"},{"issue":"9","key":"pntd.0009376.ref028","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"324","author":"SA Bozzette","year":"1991","journal-title":"N Engl J Med"},{"issue":"2","key":"pntd.0009376.ref029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199202000-00007","article-title":"Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis","volume":"6","author":"J de Gans","year":"1992","journal-title":"AIDS (London, England)"},{"issue":"2","key":"pntd.0009376.ref030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"MS Saag","year":"1992","journal-title":"N Engl J Med"},{"issue":"12","key":"pntd.0009376.ref031","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199203193261203","article-title":"A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group","volume":"326","author":"WG Powderly","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"pntd.0009376.ref032","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/22.2.315","article-title":"Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS","volume":"22","author":"PK Sharkey","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pntd.0009376.ref033","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/clinids\/23.3.556","article-title":"Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis","volume":"23","author":"V Joly","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pntd.0009376.ref034","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"AC Leenders","year":"1997","journal-title":"AIDS (London, England)"},{"issue":"7","key":"pntd.0009376.ref035","first-page":"416","article-title":"Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS","volume":"80","author":"V Chotmongkol","year":"1997","journal-title":"J Med Assoc Thai = Chotmaihet thangphaet"},{"issue":"1","key":"pntd.0009376.ref036","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"CM van der Horst","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"pntd.0009376.ref037","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS","volume":"26","author":"H Mayanja-Kizza","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0009376.ref038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"MS Saag","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pntd.0009376.ref039","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"PN Newton","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0009376.ref040","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter. randomized study","volume":"36","author":"A Vibhagool","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pntd.0009376.ref041","first-page":"293","article-title":"The efficacy of fluconazole 600 mg\/day versus itraconazole 600 mg\/day as consolidation therapy of cryptococcal meningitis in AIDS patients","volume":"86","author":"P Mootsikapun","year":"2003","journal-title":"J Med Assoc Thai = Chotmaihet thangphaet"},{"issue":"12","key":"pntd.0009376.ref042","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"PG Pappas","year":"2004","journal-title":"J Infect Dis"},{"issue":"9423","key":"pntd.0009376.ref043","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"AE Brouwer","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"1","key":"pntd.0009376.ref044","first-page":"170","article-title":"Initial treatment of cryptococcal meningitis in AIDS","volume":"36","author":"V Chotmongkol","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"10","key":"pntd.0009376.ref045","first-page":"1677","article-title":"Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients","volume":"89","author":"S Tansuphaswadikul","year":"2006","journal-title":"J Med Assoc Thai = Chotmaihet thangphaet"},{"issue":"10","key":"pntd.0009376.ref046","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1080\/00365540701383147","article-title":"Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial","volume":"39","author":"M Techapornroong","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"pntd.0009376.ref047","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/13693780701851695","article-title":"Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis","volume":"46","author":"E Milefchik","year":"2008","journal-title":"Med Mycol"},{"issue":"1","key":"pntd.0009376.ref048","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"T Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pntd.0009376.ref049","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"PG Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pntd.0009376.ref050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"JC Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pntd.0009376.ref051","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa","volume":"50","author":"AT Makadzange","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0009376.ref052","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0022-3859.65276","article-title":"Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV\/AIDS patients in India: a multicentric, randomized controlled trial","volume":"56","author":"MP Jadhav","year":"2010","journal-title":"J Postgrad Med"},{"issue":"2","key":"pntd.0009376.ref053","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"RJ Hamill","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0009376.ref054","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"A Loyse","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pntd.0009376.ref055","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"JN Jarvis","year":"2012","journal-title":"AIDS (London, England)"},{"issue":"11","key":"pntd.0009376.ref056","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis","volume":"26","author":"AT Jackson","year":"2012","journal-title":"AIDS (London, England)"},{"issue":"26","key":"pntd.0009376.ref057","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc1305981","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"JN Day","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"pntd.0009376.ref058","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis","volume":"56","author":"GP Bisson","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"26","key":"pntd.0009376.ref059","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"DR Boulware","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"pntd.0009376.ref060","first-page":"Oc14","article-title":"Combination Versus Monotherapy for the Treatment of HIV Associated Cryptococcal Meningitis","volume":"9","author":"SA Vaidhya","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"pntd.0009376.ref061","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s15010-017-1059-3","article-title":"Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience","volume":"46","author":"H Villanueva-Lozano","year":"2018","journal-title":"Infection"},{"issue":"8","key":"pntd.0009376.ref062","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1473-3099(19)30127-6","article-title":"Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial","volume":"19","author":"J Rhein","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pntd.0009376.ref063","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciy515","article-title":"Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial","volume":"68","author":"JN Jarvis","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pntd.0009376.ref064","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/heapol\/czp026","article-title":"Global health funding: how much, where it comes from and where it goes","volume":"24","author":"D McCoy","year":"2009","journal-title":"Health Policy Plan"},{"key":"pntd.0009376.ref065","volume-title":"SEXUAL AND REPRODUCTIVE HEALTH RESEARCH AND DEVELOPMENT: UNDERSTANDING THE SPECTRUM","author":"Policy Cures Research","year":"2020"},{"issue":"2","key":"pntd.0009376.ref066","doi-asserted-by":"crossref","first-page":"e001047","DOI":"10.1136\/bmjgh-2018-001047","article-title":"Investing in health R&amp;D: where we are, what limits us, and how to make progress in Africa","volume":"4","author":"V Simpkin","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pntd.0009376.ref067","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing countries- a systematic review","volume":"17","author":"C Alemayehu","year":"2018","journal-title":"Int J Equity Health"},{"issue":"1","key":"pntd.0009376.ref068","first-page":"72","article-title":"Fluconazole 1200mg or 800mg for cryptococcal meningitis treatment in Ivory Coast","volume":"27","author":"GA Kouakou","year":"2017","journal-title":"J Mycol Med"},{"issue":"4","key":"pntd.0009376.ref069","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.AOG.0000117083.33239.b5","article-title":"Trends in pregnancy rates among women with human immunodeficiency virus","volume":"103","author":"JM Blair","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"3","key":"pntd.0009376.ref070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hast.706","article-title":"Research with Pregnant Women: New Insights on Legal Decision-Making","volume":"47","author":"AC Mastroianni","year":"2017","journal-title":"Hastings Cent Rep"},{"issue":"1","key":"pntd.0009376.ref071","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jac\/dku355","article-title":"Antifungal drugs during pregnancy: an updated review","volume":"70","author":"B Pilmis","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pntd.0009376.ref072","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jwh.2017.6857","article-title":"Beyond \"Vessels and Vectors\": A Global Review of Registered HIV-Related Clinical Trials with Pregnant Women","volume":"28","author":"MN Wickremsinhe","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"20","key":"pntd.0009376.ref073","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.2018.17716","article-title":"Increasing the Participation of Pregnant Women in Clinical Trials","volume":"320","author":"K Heyrana","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"pntd.0009376.ref074","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12978-017-0419-x","article-title":"Research with pregnant women: a call to action","volume":"14","author":"MO Little","year":"2017","journal-title":"Reprod Health"},{"issue":"3","key":"pntd.0009376.ref075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/mmy\/myz084","article-title":"Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management","volume":"58","author":"KA Pastick","year":"2019","journal-title":"Med Mycol"},{"issue":"1","key":"pntd.0009376.ref076","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1002\/jia2.25416","article-title":"Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"23","author":"MW Tenforde","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pntd.0009376.ref077","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/s13063-018-3026-4","article-title":"AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial","volume":"19","author":"DS Lawrence","year":"2018","journal-title":"Trials"},{"issue":"6","key":"pntd.0009376.ref078","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/inthealth\/ihaa073","article-title":"Decolonising global health: transnational research partnerships under the spotlight","volume":"12","author":"DS Lawrence","year":"2020","journal-title":"Int Health."},{"issue":"1","key":"pntd.0009376.ref079","first-page":"1","article-title":"Decolonization is not a metaphor","volume":"1","author":"E Tuck","year":"2012","journal-title":"Decolonization: Indigeneity, Education. Society"},{"issue":"8","key":"pntd.0009376.ref080","doi-asserted-by":"crossref","first-page":"e002947","DOI":"10.1136\/bmjgh-2020-002947","article-title":"Decolonising Global (Public) Health: from Western universalism to Global pluriversalities","volume":"5","author":"C Affun-Adegbulu","year":"2020","journal-title":"BMJ Glob Health."},{"issue":"2","key":"pntd.0009376.ref081","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/inthealth\/ihy010","article-title":"On the meaning of global health and the role of global health journals","volume":"10","author":"S Abimbola","year":"2018","journal-title":"Int Health"},{"issue":"7","key":"pntd.0009376.ref082","doi-asserted-by":"crossref","first-page":"e002922","DOI":"10.1136\/bmjgh-2020-002922","article-title":"Where are the women? Gender inequalities in COVID-19 research authorship","volume":"5","author":"A-C Pinho-Gomes","journal-title":"BMJ Glob Health. 2020"},{"key":"pntd.0009376.ref083","first-page":"352","article-title":"Trends and comparison of female first authorship in high impact medical journals: observational study (1994\u20132014)","volume":"i847","author":"G Filardo","year":"2016","journal-title":"BMJ (Clinical research ed)"},{"key":"pntd.0009376.ref084","volume-title":"Gender equity in the health workforce: analysis of 104 countries","author":"M Boniol","year":"2019"},{"key":"pntd.0009376.ref085","author":"Global Health 50\/50","year":"2020","journal-title":"Power, privilege and priorities: the Global Health 50\/50 2020 report"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011240","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T17:30:16Z","timestamp":1622136616000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009376"}},"subtitle":[],"editor":[{"given":"Joseph M.","family":"Vinetz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009376","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011240","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}